Safety and efficacy of intravenously administered cidofovir in adult haematopoietic cell transplant recipients: a retrospective multicentre cohort study.
Anat SternCarolyn D AlonsoCarolina García-VidalCelia CardozoMonica A SlavinMichelle K YongSu Ann HoSeema Mehta SteinkeRobin K AveryPhilipp KoehlerChristof ScheidOliver Andreas CornelyJohan MaertensYasmine Abi AadDavid J EpsteinGenovefa A PapanicolaouDionysios NeofytosPublished in: The Journal of antimicrobial chemotherapy (2021)
One in four HCT recipients treated with IV cidofovir developed largely reversible nephrotoxicity. Careful selection of patients and close follow-up of renal function may minimize toxicity.